MRC1 and colorectal carcinoma: To gain insight into the antitumor mechanism of MMR, we studied the impact of intratumoral administration of multiple low doses of MMR in animal models of hepatocellular carcinoma (HCC) (38–41) and colorectal cancer (CRC).